Last but not least: antibody-drug conjugates in hormone receptor-positive metastatic breast cancer

Ann Oncol. 2020 Dec;31(12):1594-1596. doi: 10.1016/j.annonc.2020.10.001. Epub 2020 Oct 8.

Authors

S R Stecklein¹, P Sharma²

Affiliations

¹ Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, USA.
² Department of Internal Medicine, University of Kansas Medical Center, Westwood, USA. Electronic address: [email protected].

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Breast Neoplasms* / drug therapy
Camptothecin / analogs & derivatives
Hormones
Humans
Immunoconjugates*

Substances

Antibodies, Monoclonal, Humanized
Hormones
Immunoconjugates
sacituzumab govitecan
Camptothecin

Grants and funding

KL2 TR002367/TR/NCATS NIH HHS/United States